📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis (2010)

First Author: Vianello F

Attributed to: Expansion of the GMP facility for Stem Cell Therapy at Imperial College funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3324/haematol.2009.017178

PubMed Identifier: 20179085

Publication URI: http://europepmc.org/abstract/MED/20179085

Type: Journal Article/Review

Parent Publication: Haematologica

Issue: 7

ISSN: 0390-6078